Brief: Sol-Gel Announces Initiation Of SGT-210 Phase 1 Proof Of Concept Study In Palmoplantar Keratoderma
Jan 2 (Reuters) - Sol Gel Technologies Ltd SLGL.O :
* SOL-GEL ANNOUNCES INITIATION OF SGT-210 PHASE 1 PROOF OF
CONCEPT
STUDY IN PALMOPLANTAR KERATODERMA (PPK)
* SOL GEL TECHNOLOGIES - TOP-LINE DATA IS EXPECTED IN FIRST
HALF
OF 2021
Source text for Eikon: ID:nGNX1p61kQ
Further company coverage: SLGL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SOL-GEL TECHNOLOGIES
See all newsIsraeli dermatology firm Sol-Gel's Q2 revenue drops sharply on prior-year IP sale
SOL-GEL TECHNOLOGIES LTD. expected to post a loss of $2.57 a share - Earnings Preview
Sol-Gel Q1 revenue falls sharply on milestone payment impact
Brief: Sol-Gel Technologies Ltd. Q1 Revenue USD 100 Thousand
Brief: Sol-Gel Technologies Ltd. Announces Pricing Of Oversubscribed Underwritten Offering